scispace - formally typeset
A

Aseem Pandey

Researcher at Texas A&M University

Publications -  26
Citations -  5853

Aseem Pandey is an academic researcher from Texas A&M University. The author has contributed to research in topics: Influenza vaccine & Vaccination. The author has an hindex of 12, co-authored 23 publications receiving 5321 citations. Previous affiliations of Aseem Pandey include Sanofi Pasteur & Indian Council of Medical Research.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses

Mary Hoelscher, +10 more
- 15 Apr 2008 - 
TL;DR: An adenoviral vector-based vaccine that contains hemagglutinin protein from clade 1 and clade 2 viruses, as well as conserved nucleoprotein, to broaden the vaccine coverage against H5N1 viruses is developed.
Journal ArticleDOI

Bovine Adenoviral Vector–based H5N1 Influenza Vaccine Overcomes Exceptionally High Levels of Pre-existing Immunity Against Human Adenovirus

Neetu Singh, +3 more
- 01 May 2008 - 
TL;DR: The immunization of naïve or HAd-primed mice with BAd-H5HA bestowed full protection from morbidity and mortality following a potentially lethal challenge with A/Hong Kong/483/97, demonstrating the importance of BAd vectors as an alternate or supplement to HAd vectors for influenza pandemic preparedness.
Journal Article

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2459 more
- 01 Jan 2016 - 
Journal ArticleDOI

Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine.

Aseem Pandey, +7 more
- 14 Mar 2012 - 
TL;DR: The immunogenicity and protection results suggest possible strategies to overcome the variable levels of human immunity against adenoviruses, leading to better utilization of HAd vector-based vaccines.